ArticleCancer genomics & proteomics

Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.

Jagannath Pal et al.PubMed ↗Full text ↗

No numbers read from the abstract.